Cubist Systematic Strategies, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 189 filers reported holding HERON THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$155,901
+71.0%
56,282
+5.0%
0.00%0.0%
Q4 2023$91,157
+122.9%
53,622
+52.1%
0.00%
Q2 2023$40,899
-0.6%
35,258
+29.4%
0.00%
Q1 2023$41,129
-95.3%
27,238
-92.2%
0.00%
-100.0%
Q4 2022$876,203
-43.3%
350,481
-4.2%
0.01%
-44.4%
Q3 2022$1,544,000
+1197.5%
365,775
+754.6%
0.01%
+800.0%
Q2 2022$119,000
-81.6%
42,800
-62.1%
0.00%
-80.0%
Q1 2022$646,000
-39.7%
112,997
-3.8%
0.01%
-50.0%
Q4 2021$1,072,000
+15.0%
117,431
+34.8%
0.01%
-16.7%
Q3 2021$932,000
+62.4%
87,145
+135.5%
0.01%
+100.0%
Q2 2021$574,000
-6.4%
37,004
-2.2%
0.01%
-25.0%
Q1 2021$613,000
+246.3%
37,819
+353.4%
0.01%
+300.0%
Q4 2020$177,000
-5.3%
8,342
-33.8%
0.00%
-33.3%
Q3 2020$187,000
-19.4%
12,609
-20.2%
0.00%
-25.0%
Q2 2020$232,000
-88.0%
15,801
-90.4%
0.00%
-92.3%
Q1 2020$1,935,000
-23.7%
164,859
+52.7%
0.05%
+13.0%
Q4 2019$2,537,000
+612.6%
107,969
+641.2%
0.05%
+283.3%
Q1 2019$356,000
+5.3%
14,566
+36.3%
0.01%
-33.3%
Q3 2018$338,000
+123.8%
10,690
+174.7%
0.02%
+125.0%
Q2 2018$151,000
-52.1%
3,891
-77.6%
0.01%
-52.9%
Q4 2017$315,000
+67.6%
17,395
+125.3%
0.02%
+70.0%
Q3 2015$188,000
+347.6%
7,722
+166.3%
0.01%
+400.0%
Q1 2015$42,0002,9000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
TANG KEVIN 37,999$706,00024.13%
TANG CAPITAL MANAGEMENT LLC 5,744,096$106,783,00014.43%
BRIDGER MANAGEMENT, LLC 2,846,555$52,917,0004.15%
First Light Asset Management, LLC 1,098,723$20,425,0002.84%
Broadfin Capital, LLC 657,998$12,232,0002.66%
HIGHLAND CAPITAL MANAGEMENT LP 1,606,942$29,873,0001.75%
EMORY UNIVERSITY 129,020$2,398,0001.69%
Mesirow Financial Investment Management, Inc. 24,112$430,0001.57%
Congress Park Capital LLC 109,665$1,945,0001.54%
KINGDON CAPITAL MANAGEMENT, L.L.C. 830,821$15,445,0001.52%
View complete list of HERON THERAPEUTICS INC shareholders